Table 2 Proportion of cardiovascular prescriptions ordered by nurse practitioners, physician assistants, and primary care physicians over time, 2007–2011
2007 | 2008 | 2009 | 2010 | 2011 | |
|---|---|---|---|---|---|
Antihypertensives | |||||
Total prescriptions, N | 2,116,048 | 2,182,069 | 2,188,136 | 2,248,183 | 2,272,489 |
NP (%) | 2.0 | 2.4 | 3.0 | 3.8 | 4.2 |
PA (%) | 2.2 | 2.8 | 3.4 | 4.2 | 4.9 |
PCP (%) | 95.9 | 94.8 | 93.6 | 92.1 | 91.0 |
Anticoagulants | |||||
Total, N | 261,698 | 264,176 | 267,630 | 278,745 | 291,524 |
NP | 1.5 | 1.9 | 2.3 | 3.2 | 3.4 |
PA | 1.4 | 2.1 | 2.8 | 3.6 | 4.1 |
PCP | 97.1 | 96.0 | 94.9 | 92.6 | 92.6 |
Oral hypoglycemics | |||||
Total, N | 1,292,094 | 1,293,618 | 1,302,716 | 1,315,114 | 1,301,535 |
NP | 1.9 | 2.3 | 2.9 | 3.7 | 4.0 |
PA | 2.1 | 2.7 | 3.3 | 4.1 | 4.8 |
PCP | 96.0 | 95.0 | 93.8 | 92.3 | 91.2 |
HMG-CoA Reductase inhibitors | |||||
Total, N | 1,294,269 | 1,319,042 | 1,359,293 | 1,411,180 | 1,455,255 |
NP | 2.1 | 2.6 | 3.3 | 4.1 | 4.4 |
PA | 2.3 | 2.8 | 3.5 | 4.4 | 5.1 |
PCP | 95.6 | 94.5 | 93.2 | 91.6 | 90.5 |